Erste Asset Management Gmb H Agios Pharmaceuticals, Inc. Transaction History

Erste Asset Management Gmb H

$8.35 Trillion
Q3 2024

A detailed history of Erste Asset Management Gmb H transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 2,184,900 shares of AGIO stock, worth $93.3 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

2,184,900

Holding current value

$93.3 Million

% of portfolio

1.16%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$41.19 - $49.72 $90 Million - $109 Million	2,184,900 New	2,184,900 $97.2 Billion
Q2 2024 Nov 26, 2024	SELL	$27.55 - $48.83 $688,750 - $1.22 Million	-25,000 Reduced 1.1%	2,254,900 $97.3 Billion
Q1 2024 Nov 26, 2024	BUY	$21.32 - $34.81 $3.67 Million - $5.99 Million	172,000 Added 8.16%	2,279,900 $66.7 Billion
Q4 2023 Nov 26, 2024	BUY	$19.97 - $24.53 $8.26 Million - $10.1 Million	413,700 Added 24.42%	2,107,900 $47 Billion
Q4 2022 Nov 26, 2024	SELL	$24.81 - $31.52 $868,350 - $1.1 Million	-35,000 Reduced 2.02%	1,694,200 $47.5 Billion
Q3 2022 Nov 26, 2024	SELL	$19.51 - $34.14 $9.57 Million - $16.8 Million	-490,700 Reduced 22.46%	1,694,200 $47.9 Billion
Q2 2022 Nov 26, 2024	BUY	$17.06 - $31.42 $20 Million - $36.7 Million	1,169,600 Added 209.01%	1,729,200 $38.3 Billion
Q1 2022 Nov 22, 2024	BUY	$26.68 - $34.81 $13 Million - $16.9 Million	486,000 Added 42.51%	1,629,200 $47.4 Billion
Q4 2021 Nov 22, 2024	SELL	$29.58 - $49.78 $17.9 Million - $30.2 Million	-606,700 Reduced 27.77%	1,578,200 $53 Billion
Q3 2021 Nov 22, 2024	BUY	$41.92 - $58.18 $2.49 Million - $3.45 Million	59,300 Added 5.47%	1,143,200 $52.8 Billion
Q2 2021 Nov 22, 2024	BUY	$52.06 - $61.27 $1.56 Million - $1.84 Million	30,000 Added 2.85%	1,083,900 $59.6 Billion
Q4 2020 Nov 22, 2024	BUY	$33.21 - $46.54 $2.21 Million - $3.09 Million	66,400 Added 6.72%	1,053,900 $46.9 Billion
Q3 2020 Nov 22, 2024	SELL	$33.87 - $55.93 $40.6 Million - $67 Million	-1,197,400 Reduced 54.8%	987,500 $34.5 Billion
Q2 2020 Nov 22, 2024	SELL	$34.45 - $53.48 $4.32 Million - $6.7 Million	-125,300 Reduced 12.1%	910,100 $48.6 Billion
Q1 2020 Nov 22, 2024	SELL	$31.52 - $53.81 $1.36 Million - $2.33 Million	-43,300 Reduced 4.01%	1,035,400 $36.7 Billion
Q4 2019 Nov 22, 2024	SELL	$30.08 - $50.59 $33.3 Million - $56 Million	-1,106,200 Reduced 50.63%	1,078,700 $51.8 Billion
Q3 2019 Nov 22, 2024	BUY	$32.4 - $49.58 $3.76 Million - $5.75 Million	116,000 Added 16.7%	810,700 $26.4 Billion
Q2 2019 Nov 22, 2024	BUY	$46.17 - $68.1 $5.54 Million - $8.17 Million	120,000 Added 20.88%	694,700 $34.6 Billion
Q1 2019 Nov 22, 2024	SELL	$45.92 - $67.67 $73.9 Million - $109 Million	-1,610,200 Reduced 73.7%	574,700 $38.6 Billion
Q4 2018 Nov 26, 2024	SELL	$42.73 - $76.53 $69.4 Million - $124 Million	-1,625,300 Reduced 74.39%	559,600 $25.3 Billion

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.34B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Account

Erste Asset Management Gmb H Agios Pharmaceuticals, Inc. Transaction History